ArticleStudy of the Antifibrotic Effect of Olmesartan on the Carbon Tetrachloride- Induced liver Toxicity in Rats
ArticleStudy of the Antifibrotic Effect of Olmesartan on the Carbon Tetrachloride- Induced liver Toxicity in Rats
ArticleEvaluation Of Possible Antifibrotic Effect Of Cholecalciferol, Calci-Potriol, Aliskiren, Ramipril And Eprosartan On Carbon Tetrachloride Induced Liver Fibrosis In Albino Rats
ArticleEvaluation Of Possible Antifibrotic Effect Of Cholecalciferol, Calci-Potriol, Aliskiren, Ramipril And Eprosartan On Carbon Tetrachloride Induced Liver Fibrosis In Albino Rats
ArticleLosartan prevents methotrexate-induced liver and lung injury in rats via targeting PPAR-γ/TGF-β1/SMAD3 and Nrf2/redox signaling
ArticleLosartan prevents methotrexate-induced liver and lung injury in rats via targeting PPAR-γ/TGF-β1/SMAD3 and Nrf2/redox signaling
ArticlePotential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats
ArticlePotential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats
ArticleNatural polyphenols target the TGF-β/caspase-3 signaling pathway in CCl4-induced liver fibrosis in rats
ArticleNatural polyphenols target the TGF-β/caspase-3 signaling pathway in CCl4-induced liver fibrosis in rats
ArticleAdaptation of TIMP-1/P21 Signaling Pathways in Hepatic Fibrosis Induced in Albino Rats Using Telmisartan with Vitamin D
ArticleAdaptation of TIMP-1/P21 Signaling Pathways in Hepatic Fibrosis Induced in Albino Rats Using Telmisartan with Vitamin D
ArticleAliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression
ArticleAliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression
ArticleInvestigating Pirfenidone and Vitamin D for Targeting Cardiac and Renal Fibrotic Pathways in Experimentally-Induced Animal Model
ArticleInvestigating Pirfenidone and Vitamin D for Targeting Cardiac and Renal Fibrotic Pathways in Experimentally-Induced Animal Model
EkbALISKIREN AND FENOFIBRATE ATTEUATE LIVER FIBROSIS VIA TARGETING TGF- β1/ SMAD SIGNALING PATHWAY AND INDUCING HGF EXPRESSION
EkbALISKIREN AND FENOFIBRATE ATTEUATE LIVER FIBROSIS VIA TARGETING TGF- β1/ SMAD SIGNALING PATHWAY AND INDUCING HGF EXPRESSION